Evidence map›Paper›PMID 36424864›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis.

Pranay Sinha, Chinnaiyan Ponnuraja, Nikhil Gupte, Senbagavalli Prakash Babu, Samyra R Cox, Sonali Sarkar, Vidya Mave, Mandar Paradkar, Chelsie Cintron, S Govindarajan and 17 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Energy dense nutritional supplements improve weight gain among malnourished adults with drug-sensitive pulmonary tuberculosis: An open-label randomized controlled trial in Faridabad, India.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Trial
  4. Article
  5. Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis.American journal of respiratory and critical care medicine · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Pranay SinhaSection of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-4233-0871
Chinnaiyan PonnurajaIndian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Nikhil GupteByramjee Jeejeebhoy Government Medical College, Sassoon General Hospitals-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Senbagavalli Prakash BabuJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Samyra R CoxDivision of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Sonali SarkarJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Vidya MaveByramjee Jeejeebhoy Government Medical College, Sassoon General Hospitals-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Mandar ParadkarByramjee Jeejeebhoy Government Medical College, Sassoon General Hospitals-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Chelsie CintronSection of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
S GovindarajanJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Aarti KinikarByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, Maharashtra, India.
Nadesan PriyaChristian Medical College, Vellore, Tamil Nadu, India.
Sanjay GaikwadByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, Maharashtra, India.
Balamugesh ThangakunamChristian Medical College, Vellore, Tamil Nadu, India.
Arutselvi DevarajanProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Mythili DhanasekaranProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Jeffrey A TornheimDivision of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Amita GuptaDivision of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Padmini SalgameCenter for Emerging Pathogens, Department of Medicine, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
Devashyam Jesudas ChristopherChristian Medical College, Vellore, Tamil Nadu, India.
Hardy KornfeldDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Vijay ViswanathanProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Jerrold J EllnerCenter for Emerging Pathogens, Department of Medicine, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
C Robert HorsburghSection of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Akshay N GupteDivision of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Chandrasekaran PadmapriyadarsiniIndian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Natasha S HochbergSection of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Funding

BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
Whole Genome Sequencing of Drug Resistant Tuberculosis in India: Genotype-Phenotype Correlation, Clinical Impact of Resistance, and Sequencing Directly from SputumK23AI135102 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TORNHEIM, JEFFREY · 2018 to 2021
$776k
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung DiseaseK99AI151094 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GUPTE, AKSHAY NITIN · 2020 to 2021
$271k
NIAID NIH HHS K23 AI135102NIAID NIH HHS K99 AI151094NIAID NIH HHS T32 AI052074Wellcome Trust
6 · The paper itself

Abstract

backgroundUndernutrition is the leading risk factor for tuberculosis (TB) globally. Its impact on treatment outcomes is poorly defined.

methodsWe conducted a prospective cohort analysis of adults with drug-sensitive pulmonary TB at 5 sites from 2015-2019. Using multivariable Poisson regression, we assessed associations between unfavorable outcomes and nutritional status based on body mass index (BMI) nutritional status at treatment initiation, BMI prior to TB disease, stunting, and stagnant or declining BMI after 2 months of TB treatment. Unfavorable outcome was defined as a composite of treatment failure, death, or relapse within 6 months of treatment completion.

resultsSevere undernutrition (BMI <16 kg/m2) at treatment initiation and severe undernutrition before the onset of TB disease were both associated with unfavorable outcomes (adjusted incidence rate ratio [aIRR], 2.05; 95% confidence interval [CI], 1.42-2.91 and aIRR, 2.20; 95% CI, 1.16-3.94, respectively). Additionally, lack of BMI increase after treatment initiation was associated with increased unfavorable outcomes (aIRR, 1.81; 95% CI, 1.27-2.61). Severe stunting (height-for-age z score <-3) was associated with unfavorable outcomes (aIRR, 1.52; 95% CI, 1.00-2.24). Severe undernutrition at treatment initiation and lack of BMI increase during treatment were associated with a 4- and 5-fold higher rate of death, respectively.

conclusionsPremorbid undernutrition, undernutrition at treatment initiation, lack of BMI increase after intensive therapy, and severe stunting are associated with unfavorable TB treatment outcomes. These data highlight the need to address this widely prevalent TB comorbidity. Nutritional assessment should be integrated into standard TB care.

Indexed as

MalnutritionTuberculosisAdultHumansIndiaProspective StudiesTreatment OutcomeIndiamalnutritionoutcomestuberculosisundernutrition

Identifiers

PMID36424864
PMCPMC10319769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.